📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. (2019)

First Author: Kohn DB

Attributed to: Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2018.08.024

PubMed Identifier: 30194989

Publication URI: http://europepmc.org/abstract/MED/30194989

Type: Journal Article/Review

Volume: 143

Parent Publication: The Journal of allergy and clinical immunology

Issue: 3

ISSN: 0091-6749